eHealth ERA

The vision of transparent European healthcare systems which deliver high quality healthcare to all citizens independent of their location when in need of care is coming closer to reality. A European eHealth space facilitates this development.

The overall goal of the eHealth ERA project is to contribute to greater transparency of national eHealth strategies and implementation activities as well as innovationoriented research and technology development (RTD) initiatives. Thereby the project aimed at fostering an effective European Research and innovation Area (ERA) in eHealth.

Towards these ends, the project has contributed to:

  • creating greater transparency with regard to national eHealth strategies and measures to achieve national eHealth visions,
  • identifying and analysing priority deployment goals and resulting RTD needs,
  • exchanging experience in developing and managing eHealth strategies and programmes,
  • recommending sustainable mechanisms for effective trans-national cooperation between several of the participating states for mutual benefit.

For further information, please visit:
http://www.ehealth-era.org

Project co-ordinator:
empirica GmbH, Bonn, Germany

Partners:

  • National Research and Development Centre for Welfare and Health (STAKES), Helsinki, Finland
  • Consiglio Nazionale delle Ricerche (CNR), Rome, Italy
  • Centre of Innovation,Technology Transfer and University Development (CITTRU), Jagiellonian University, Krakow, Poland
  • Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
  • Engineering and Physical Sciences Research Council (EPSRC), Swindon, United Kingdom
  • Imperial College, London, United Kingdom

Timetable: 27 months (4/05 - 6/07)

Total cost: € 1.065.233

EC funding: € 950.000

Instrument: SSA

Project Identifier: IST-2004-015854

Most Popular Now

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...